![Clayton Duncan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Clayton Duncan
Chief Executive Officer at Pamlico BioPharma, Inc.
Profile
Clayton I.
Duncan was the founder of Synereca Pharmaceuticals, Inc. founded in 2009, where he held the title of Chairman & Chief Executive Officer.
Currently, he is the Chairman & Chief Executive Officer at Otologic Pharmaceutics, Inc. and Pamlico BioPharma, Inc. Mr. Duncan's former positions include Chairman, President & Chief Executive Officer at Incara Pharmaceuticals Corp., Chief Executive Officer at Entegrion, Inc., Chief Executive Officer at Sphinx Pharmaceuticals Corp, Chief Executive Officer at Ercole Biotech, Inc., Chief Executive Officer at Research Triangle Park, and Principal at Accele Venture Management LLC.
Mr. Duncan's education history includes an undergraduate degree from the University of California, Santa Barbara and an MBA from The University of North Carolina at Charlotte.
Clayton Duncan active positions
Companies | Position | Start |
---|---|---|
Pamlico BioPharma, Inc.
![]() Pamlico BioPharma, Inc. BiotechnologyHealth Technology Pamlico BioPharma, Inc. provides antibody therapeutics services. It develops fully-human monoclonal antibody (hmAb) therapeutics for the rapid diagnosis and treatment of infectious diseases and cancer. The firms lead program is focused on severe pneumonia caused by streptococcus pneumoniae (SPN), and is in preclinical IND-directed activities for a mAb cocktail and a companion point-of-care (POC) diagnostic against three serotypes that account for over 40% of SPN infections. The company was founded on 18 December, 2014 and is headquartered in Oklahoma, OK. | Chief Executive Officer | - |
Otologic Pharmaceutics, Inc.
![]() Otologic Pharmaceutics, Inc. Pharmaceuticals: MajorHealth Technology Otologic Pharmaceutics, Inc. develops treatment for acute hearing loss. Its product HPN1010 is an oral medication to treat acute hearing loss to reduce the development of permanent hearing disorders. The company was founded by Richard Kopke, Robert A. Floyd and Dave karlman and is headquartered in Oklahoma City, OK. | Chief Executive Officer | - |
Former positions of Clayton Duncan
Companies | Position | End |
---|---|---|
Accele Biopharma, Inc.
![]() Accele Biopharma, Inc. Investment ManagersFinance Accele Biopharma, Inc. (Accele Biopharma) is a venture capital firm founded in 2011. The firm is headquartered in Oklahoma City, Oklahoma. | Chief Executive Officer | 01/09/2017 |
Incara Pharmaceuticals Corp. | Director/Board Member | 09/08/2004 |
Sphinx Pharmaceuticals Corp | Corporate Officer/Principal | - |
Entegrion, Inc.
![]() Entegrion, Inc. Pharmaceuticals: MajorHealth Technology Entegrion, Inc. develops biological technologies, drugs, and pharmaceuticals. It applies public and private funds to design, develop, and deliver products that address unmet needs in military healthcare and have commercial applications. The company was founded by Arthur P. Bode in 2002 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
Ercole Biotech, Inc.
![]() Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Corporate Officer/Principal | - |
Training of Clayton Duncan
University of California, Santa Barbara | Undergraduate Degree |
The University of North Carolina at Charlotte | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 10 |
---|---|
Incara Pharmaceuticals Corp. | Health Technology |
Entegrion, Inc.
![]() Entegrion, Inc. Pharmaceuticals: MajorHealth Technology Entegrion, Inc. develops biological technologies, drugs, and pharmaceuticals. It applies public and private funds to design, develop, and deliver products that address unmet needs in military healthcare and have commercial applications. The company was founded by Arthur P. Bode in 2002 and is headquartered in Durham, NC. | Health Technology |
Synereca Pharmaceuticals, Inc.
![]() Synereca Pharmaceuticals, Inc. Medical DistributorsDistribution Services Synereca Pharmaceuticals, Inc. develops orally active drugs that restore the effectiveness of existing antibiotics. It focuses on compounds that enhance the activity of Colistin against gram-negative bacteria without enhancing its toxicity. The company was founded in 2009 by Clayton I. Duncan, Stephen B. Bocckino and Bennett W. Love and is headquartered in Oklahoma City, OK. | Distribution Services |
Accele Biopharma, Inc.
![]() Accele Biopharma, Inc. Investment ManagersFinance Accele Biopharma, Inc. (Accele Biopharma) is a venture capital firm founded in 2011. The firm is headquartered in Oklahoma City, Oklahoma. | Finance |
Sphinx Pharmaceuticals Corp | Health Technology |
Ercole Biotech, Inc.
![]() Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Commercial Services |
Research Triangle Park | |
Accele Venture Management LLC
![]() Accele Venture Management LLC Investment ManagersFinance Accele Venture Management LLC is a Venture Capital firm, a subsidiary of Accele Biopharma, Inc. founded in 2011. Accele Venture Management LLC is headquartered in Oklahoma City. | Finance |
Otologic Pharmaceutics, Inc.
![]() Otologic Pharmaceutics, Inc. Pharmaceuticals: MajorHealth Technology Otologic Pharmaceutics, Inc. develops treatment for acute hearing loss. Its product HPN1010 is an oral medication to treat acute hearing loss to reduce the development of permanent hearing disorders. The company was founded by Richard Kopke, Robert A. Floyd and Dave karlman and is headquartered in Oklahoma City, OK. | Health Technology |
Pamlico BioPharma, Inc.
![]() Pamlico BioPharma, Inc. BiotechnologyHealth Technology Pamlico BioPharma, Inc. provides antibody therapeutics services. It develops fully-human monoclonal antibody (hmAb) therapeutics for the rapid diagnosis and treatment of infectious diseases and cancer. The firms lead program is focused on severe pneumonia caused by streptococcus pneumoniae (SPN), and is in preclinical IND-directed activities for a mAb cocktail and a companion point-of-care (POC) diagnostic against three serotypes that account for over 40% of SPN infections. The company was founded on 18 December, 2014 and is headquartered in Oklahoma, OK. | Health Technology |
- Stock Market
- Insiders
- Clayton Duncan